Cargando…

Efficacy of a high-potency multivalent foot-and-mouth disease virus vaccine in cattle against heterologous challenge with a field virus from the emerging A/ASIA/G-VII lineage

In 2015, outbreaks of foot-and-mouth disease (FMD) in the Middle East were discovered to be caused by a viral lineage (A/ASIA/G-VII), which has recently emerged from the Indian sub-continent. In vitro vaccine matching data generated by the World Reference Laboratory (WRLFMD) indicated that A/ASIA/G-...

Descripción completa

Detalles Bibliográficos
Autores principales: Waters, Ryan, Ludi, Anna B., Fowler, Veronica L., Wilsden, Ginette, Browning, Clare, Gubbins, Simon, Statham, Bob, Bin-Tarif, Abdelghani, Mioulet, Valerie, King, David J., Colenutt, Claire, Brown, Emma, Hudelet, Pascal, King, Donald P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5864508/
https://www.ncbi.nlm.nih.gov/pubmed/29506922
http://dx.doi.org/10.1016/j.vaccine.2018.02.016
_version_ 1783308527807234048
author Waters, Ryan
Ludi, Anna B.
Fowler, Veronica L.
Wilsden, Ginette
Browning, Clare
Gubbins, Simon
Statham, Bob
Bin-Tarif, Abdelghani
Mioulet, Valerie
King, David J.
Colenutt, Claire
Brown, Emma
Hudelet, Pascal
King, Donald P.
author_facet Waters, Ryan
Ludi, Anna B.
Fowler, Veronica L.
Wilsden, Ginette
Browning, Clare
Gubbins, Simon
Statham, Bob
Bin-Tarif, Abdelghani
Mioulet, Valerie
King, David J.
Colenutt, Claire
Brown, Emma
Hudelet, Pascal
King, Donald P.
author_sort Waters, Ryan
collection PubMed
description In 2015, outbreaks of foot-and-mouth disease (FMD) in the Middle East were discovered to be caused by a viral lineage (A/ASIA/G-VII), which has recently emerged from the Indian sub-continent. In vitro vaccine matching data generated by the World Reference Laboratory (WRLFMD) indicated that A/ASIA/G-VII field viruses were poorly matched with vaccines (A-SAU-95, A22 IRQ and A-IRN-05) that are already used in the region. In order to assess the likely performance of one of these commercially available FMD vaccines, sixteen cattle were vaccinated with a polyvalent vaccine which contained two serotype A components (A-SAU-95 and A-IRN-05) with a homologous potency of at least 6PD(50), and two cattle were left unvaccinated as controls. Twenty-one days later, all 18 cattle were challenged by tongue inoculation with an FMDV field isolate A/IRN/22/2015 from the A/ASIA/G-VII lineage, in line with the European Pharmacopeia PPG test conditions. The two control animals developed generalised FMD, and 7/16 vaccinated animals developed at least one foot lesion, thus only 56.3% were defined as protected. For the vaccine components, there was a significant increase in the probability of protection with increasing serological titres for A-SAU-95 (p = 0.03), but not for A-IRN-05 (p = 0.42). Analysis of FMDV in blood and nasal swabs suggested that vaccination reduced shedding and potential onward spread of FMD virus even if the animal developed foot lesions. In summary, the results from this study suggest that whilst this vaccine would not be appropriate for use in an emergency situation (in previously FMD-free countries), it may be partially effective in the field in endemic countries where repeat prophylactic vaccination is practiced. For emergency reactive vaccination, the findings from this study support the idea that a new vaccine strain should be developed that is tailored to the A/ASIA/G-VII lineage.
format Online
Article
Text
id pubmed-5864508
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier Science
record_format MEDLINE/PubMed
spelling pubmed-58645082018-03-27 Efficacy of a high-potency multivalent foot-and-mouth disease virus vaccine in cattle against heterologous challenge with a field virus from the emerging A/ASIA/G-VII lineage Waters, Ryan Ludi, Anna B. Fowler, Veronica L. Wilsden, Ginette Browning, Clare Gubbins, Simon Statham, Bob Bin-Tarif, Abdelghani Mioulet, Valerie King, David J. Colenutt, Claire Brown, Emma Hudelet, Pascal King, Donald P. Vaccine Article In 2015, outbreaks of foot-and-mouth disease (FMD) in the Middle East were discovered to be caused by a viral lineage (A/ASIA/G-VII), which has recently emerged from the Indian sub-continent. In vitro vaccine matching data generated by the World Reference Laboratory (WRLFMD) indicated that A/ASIA/G-VII field viruses were poorly matched with vaccines (A-SAU-95, A22 IRQ and A-IRN-05) that are already used in the region. In order to assess the likely performance of one of these commercially available FMD vaccines, sixteen cattle were vaccinated with a polyvalent vaccine which contained two serotype A components (A-SAU-95 and A-IRN-05) with a homologous potency of at least 6PD(50), and two cattle were left unvaccinated as controls. Twenty-one days later, all 18 cattle were challenged by tongue inoculation with an FMDV field isolate A/IRN/22/2015 from the A/ASIA/G-VII lineage, in line with the European Pharmacopeia PPG test conditions. The two control animals developed generalised FMD, and 7/16 vaccinated animals developed at least one foot lesion, thus only 56.3% were defined as protected. For the vaccine components, there was a significant increase in the probability of protection with increasing serological titres for A-SAU-95 (p = 0.03), but not for A-IRN-05 (p = 0.42). Analysis of FMDV in blood and nasal swabs suggested that vaccination reduced shedding and potential onward spread of FMD virus even if the animal developed foot lesions. In summary, the results from this study suggest that whilst this vaccine would not be appropriate for use in an emergency situation (in previously FMD-free countries), it may be partially effective in the field in endemic countries where repeat prophylactic vaccination is practiced. For emergency reactive vaccination, the findings from this study support the idea that a new vaccine strain should be developed that is tailored to the A/ASIA/G-VII lineage. Elsevier Science 2018-03-27 /pmc/articles/PMC5864508/ /pubmed/29506922 http://dx.doi.org/10.1016/j.vaccine.2018.02.016 Text en © 2018 The Pirbright Institute http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Waters, Ryan
Ludi, Anna B.
Fowler, Veronica L.
Wilsden, Ginette
Browning, Clare
Gubbins, Simon
Statham, Bob
Bin-Tarif, Abdelghani
Mioulet, Valerie
King, David J.
Colenutt, Claire
Brown, Emma
Hudelet, Pascal
King, Donald P.
Efficacy of a high-potency multivalent foot-and-mouth disease virus vaccine in cattle against heterologous challenge with a field virus from the emerging A/ASIA/G-VII lineage
title Efficacy of a high-potency multivalent foot-and-mouth disease virus vaccine in cattle against heterologous challenge with a field virus from the emerging A/ASIA/G-VII lineage
title_full Efficacy of a high-potency multivalent foot-and-mouth disease virus vaccine in cattle against heterologous challenge with a field virus from the emerging A/ASIA/G-VII lineage
title_fullStr Efficacy of a high-potency multivalent foot-and-mouth disease virus vaccine in cattle against heterologous challenge with a field virus from the emerging A/ASIA/G-VII lineage
title_full_unstemmed Efficacy of a high-potency multivalent foot-and-mouth disease virus vaccine in cattle against heterologous challenge with a field virus from the emerging A/ASIA/G-VII lineage
title_short Efficacy of a high-potency multivalent foot-and-mouth disease virus vaccine in cattle against heterologous challenge with a field virus from the emerging A/ASIA/G-VII lineage
title_sort efficacy of a high-potency multivalent foot-and-mouth disease virus vaccine in cattle against heterologous challenge with a field virus from the emerging a/asia/g-vii lineage
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5864508/
https://www.ncbi.nlm.nih.gov/pubmed/29506922
http://dx.doi.org/10.1016/j.vaccine.2018.02.016
work_keys_str_mv AT watersryan efficacyofahighpotencymultivalentfootandmouthdiseasevirusvaccineincattleagainstheterologouschallengewithafieldvirusfromtheemergingaasiagviilineage
AT ludiannab efficacyofahighpotencymultivalentfootandmouthdiseasevirusvaccineincattleagainstheterologouschallengewithafieldvirusfromtheemergingaasiagviilineage
AT fowlerveronical efficacyofahighpotencymultivalentfootandmouthdiseasevirusvaccineincattleagainstheterologouschallengewithafieldvirusfromtheemergingaasiagviilineage
AT wilsdenginette efficacyofahighpotencymultivalentfootandmouthdiseasevirusvaccineincattleagainstheterologouschallengewithafieldvirusfromtheemergingaasiagviilineage
AT browningclare efficacyofahighpotencymultivalentfootandmouthdiseasevirusvaccineincattleagainstheterologouschallengewithafieldvirusfromtheemergingaasiagviilineage
AT gubbinssimon efficacyofahighpotencymultivalentfootandmouthdiseasevirusvaccineincattleagainstheterologouschallengewithafieldvirusfromtheemergingaasiagviilineage
AT stathambob efficacyofahighpotencymultivalentfootandmouthdiseasevirusvaccineincattleagainstheterologouschallengewithafieldvirusfromtheemergingaasiagviilineage
AT bintarifabdelghani efficacyofahighpotencymultivalentfootandmouthdiseasevirusvaccineincattleagainstheterologouschallengewithafieldvirusfromtheemergingaasiagviilineage
AT miouletvalerie efficacyofahighpotencymultivalentfootandmouthdiseasevirusvaccineincattleagainstheterologouschallengewithafieldvirusfromtheemergingaasiagviilineage
AT kingdavidj efficacyofahighpotencymultivalentfootandmouthdiseasevirusvaccineincattleagainstheterologouschallengewithafieldvirusfromtheemergingaasiagviilineage
AT colenuttclaire efficacyofahighpotencymultivalentfootandmouthdiseasevirusvaccineincattleagainstheterologouschallengewithafieldvirusfromtheemergingaasiagviilineage
AT brownemma efficacyofahighpotencymultivalentfootandmouthdiseasevirusvaccineincattleagainstheterologouschallengewithafieldvirusfromtheemergingaasiagviilineage
AT hudeletpascal efficacyofahighpotencymultivalentfootandmouthdiseasevirusvaccineincattleagainstheterologouschallengewithafieldvirusfromtheemergingaasiagviilineage
AT kingdonaldp efficacyofahighpotencymultivalentfootandmouthdiseasevirusvaccineincattleagainstheterologouschallengewithafieldvirusfromtheemergingaasiagviilineage